Your browser doesn't support javascript.
loading
Adjunctive Rifampicin Increases Antibiotic Efficacy in Group A Streptococcal Tissue Infection Models.
Bergsten, H; Palma Medina, L M; Morgan, M; Moll, K; Skutlaberg, D H; Skrede, S; Wajima, T; Svensson, M; Norrby-Teglund, A.
Afiliação
  • Bergsten H; Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Palma Medina LM; Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Morgan M; Royal Devon and Exeter Hospital, Exeter, United Kingdom.
  • Moll K; Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Skutlaberg DH; Department of Microbiology, Haukeland University Hospital, Bergen, Norway.
  • Skrede S; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Wajima T; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Svensson M; Department of Medicine, Haukeland University Hospital, Bergen, Norway.
  • Norrby-Teglund A; Department of Microbiology, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
Antimicrob Agents Chemother ; 65(11): e0065821, 2021 10 18.
Article em En | MEDLINE | ID: mdl-34491807

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Estreptocócicas / Infecções dos Tecidos Moles Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Estreptocócicas / Infecções dos Tecidos Moles Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suécia